Loading chat...
NY A01792
Bill
Status
1/23/2023
Primary Sponsor
Jeffrey Dinowitz
Click for details
AI Summary
-
Requires all individual health insurance policies providing hospital, surgical, medical, laboratory, or diagnostic X-ray coverage to include testing for familial dysautonomia, Canavan's disease, and Tay-Sachs.
-
Mandates coverage inclusion for all new policies at inception and for existing policies at their anniversary date, subject to evidence of insurability.
-
Allows insurers to apply annual deductibles and co-insurance to genetic disease testing consistent with other policy benefits, as determined by the superintendent.
-
Permits laboratory acknowledgment of test receipt to serve as sufficient confidentiality-protecting evidence of testing without requiring disclosure of test results.
-
Applies coverage requirements to individual policies, group policies, and medical/hospital/health service corporations, effective immediately upon enactment.
Legislative Description
Provides that every policy which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or diagnostic X-rays shall provide coverage for testing of familial dysautonomia, Canavan's disease and Tay-Sachs; provides that in order to maintain the confidentiality of persons tested, receipt of acknowledgement from the testing facility shall be deemed sufficient evidence of testing.
Last Action
referred to insurance
1/3/2024